Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Dermatologists | 5 | 2021 | 435 | 1.08 | Why? |
| Psoriasis | 4 | 2021 | 1739 | 0.75 | Why? |
| Outpatient Clinics, Hospital | 2 | 2020 | 523 | 0.73 | Why? |
| Dermatology | 4 | 2020 | 1999 | 0.70 | Why? |
| Pemphigus | 1 | 2020 | 163 | 0.68 | Why? |
| Dermatitis, Atopic | 2 | 2021 | 714 | 0.62 | Why? |
| Dermatologic Agents | 2 | 2018 | 489 | 0.58 | Why? |
| Organizational Policy | 1 | 2020 | 694 | 0.57 | Why? |
| Skin Diseases, Viral | 1 | 2020 | 436 | 0.53 | Why? |
| Exanthema | 1 | 2020 | 1097 | 0.41 | Why? |
| Skin | 2 | 2020 | 2096 | 0.41 | Why? |
| Skin Diseases | 2 | 2020 | 2509 | 0.32 | Why? |
| Practice Patterns, Physicians' | 1 | 2021 | 4927 | 0.24 | Why? |
| Panniculitis, Lupus Erythematosus | 1 | 2019 | 5 | 0.20 | Why? |
| Direct-to-Consumer Advertising | 1 | 2017 | 7 | 0.18 | Why? |
| Alopecia Areata | 1 | 2020 | 140 | 0.18 | Why? |
| Brain Waves | 1 | 2017 | 37 | 0.18 | Why? |
| Phosphodiesterase 4 Inhibitors | 1 | 2018 | 112 | 0.17 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.17 | Why? |
| Biological Factors | 1 | 2020 | 276 | 0.16 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 9335 | 0.16 | Why? |
| Neural Pathways | 1 | 2017 | 155 | 0.16 | Why? |
| Keratosis, Actinic | 1 | 2016 | 54 | 0.15 | Why? |
| Food Preferences | 1 | 2017 | 128 | 0.15 | Why? |
| Thalidomide | 1 | 2018 | 247 | 0.15 | Why? |
| Alopecia | 1 | 2020 | 351 | 0.15 | Why? |
| Neurosciences | 1 | 2017 | 148 | 0.15 | Why? |
| Granuloma | 1 | 2016 | 88 | 0.15 | Why? |
| Hidradenitis Suppurativa | 1 | 2020 | 309 | 0.14 | Why? |
| Diterpenes | 1 | 2016 | 157 | 0.14 | Why? |
| Biological Therapy | 1 | 2018 | 456 | 0.13 | Why? |
| Choice Behavior | 1 | 2017 | 319 | 0.13 | Why? |
| New Zealand | 1 | 2020 | 2073 | 0.13 | Why? |
| Facial Dermatoses | 1 | 2016 | 222 | 0.12 | Why? |
| Arthritis, Psoriatic | 1 | 2018 | 625 | 0.12 | Why? |
| Consumer Behavior | 1 | 2017 | 544 | 0.11 | Why? |
| Physician-Patient Relations | 1 | 2020 | 1266 | 0.10 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.09 | Why? |
| Australia | 1 | 2020 | 6306 | 0.08 | Why? |
| Alcohol Drinking | 1 | 2018 | 1663 | 0.08 | Why? |
| Clinical Competence | 1 | 2021 | 3263 | 0.08 | Why? |
| Biological Products | 1 | 2020 | 2331 | 0.07 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.07 | Why? |
| Smoking | 1 | 2018 | 3358 | 0.07 | Why? |
| Humans | 19 | 2021 | 930598 | 0.07 | Why? |
| Pediatrics | 1 | 2020 | 2969 | 0.07 | Why? |
| Europe | 1 | 2021 | 12702 | 0.07 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.07 | Why? |
| Middle Aged | 8 | 2020 | 270681 | 0.06 | Why? |
| Italy | 3 | 2020 | 38444 | 0.06 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.06 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.05 | Why? |
| Hospitals | 1 | 2020 | 11793 | 0.05 | Why? |
| Male | 9 | 2020 | 367725 | 0.05 | Why? |
| Female | 9 | 2020 | 380317 | 0.05 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.05 | Why? |
| Aged | 6 | 2020 | 215776 | 0.05 | Why? |
| Biopsy | 2 | 2019 | 2811 | 0.05 | Why? |
| Food Additives | 1 | 2017 | 27 | 0.05 | Why? |
| Food Labeling | 1 | 2017 | 18 | 0.04 | Why? |
| Nutritive Value | 1 | 2017 | 100 | 0.04 | Why? |
| Lymphoma, T-Cell, Cutaneous | 1 | 2019 | 121 | 0.04 | Why? |
| Child | 3 | 2021 | 70012 | 0.04 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.04 | Why? |
| Brain Mapping | 1 | 2017 | 228 | 0.04 | Why? |
| Gels | 1 | 2016 | 111 | 0.04 | Why? |
| Administration, Cutaneous | 1 | 2016 | 229 | 0.04 | Why? |
| Prednisone | 1 | 2019 | 652 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2018 | 48226 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2020 | 25144 | 0.03 | Why? |
| Remission Induction | 1 | 2016 | 950 | 0.03 | Why? |
| Dermoscopy | 1 | 2016 | 346 | 0.03 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.03 | Why? |
| Adult | 5 | 2021 | 244371 | 0.03 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 1454 | 0.02 | Why? |
| Cognition | 1 | 2017 | 1394 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Treatment Outcome | 3 | 2020 | 51732 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.02 | Why? |
| Perception | 1 | 2017 | 2827 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.02 | Why? |
| Emotions | 1 | 2017 | 2418 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2019 | 7268 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2019 | 7220 | 0.02 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.02 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Biomarkers | 1 | 2019 | 23361 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.01 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.01 | Why? |
Diotallevi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(98)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(33)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_